Multivessel versus culprit-only revascularization: one time versus staged procedures for the ACS population

Abstract

Multivessel coronary artery disease is a frequent finding in patients with acute myocardial infarction. The proper management of nonculprit lesions in the setting of acute coronary syndromes has historically been a topic of major debate. Despite current guidelines that clearly recommend treatment only of the culprit lesion in this setting, unless there is hemodynamic instability, there is still no consensus about the best treatment strategy for these patients. This article summarizes international experience and authors' opinion about this controversial topic.